IBD Evidence

Article

The Crohn's Disease Exclusion Diet, Explained

Updated 4 min read 20 citations

Analytical chemistry bench fitted with glassware for titration and pH measurement
Jean-Pierre from Cosne-Cours-sur-Loire (Nièvre, Burgundy… · CC BY-SA 2.0 · Wikimedia Commons

Our diet page covers the full landscape of dietary approaches to inflammatory bowel disease and gives the Crohn's Disease Exclusion Diet, or CDED, one row in a summary table: "growing randomised evidence… promising." That's accurate but thin for what is now one of the more actively studied dietary interventions in paediatric and adult Crohn's disease. Here's what the trials behind that one-line summary actually tested.

What CDED is, and how it differs from exclusive enteral nutrition

Exclusive enteral nutrition (EEN) — a liquid formula diet taken exclusively for several weeks, covered in more depth on our diet page — is the intervention with the longest track record for inducing remission in paediatric Crohn's disease. CDED was developed as a whole-food alternative that follows structured phases and, in its original formulation, is combined with partial enteral nutrition rather than requiring a period of formula-only intake. A randomised controlled trial found that CDED plus partial enteral nutrition induces sustained remission, testing this combined approach directly against comparators in a controlled trial design [14].

The evidence in adults specifically

Most of the foundational work on structured exclusion diets was done in children, so the extension to adults is worth tracking separately. An open-label pilot randomised trial tested CDED for both induction and maintenance of remission specifically in adults with mild-to-moderate Crohn's disease ("The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial", The Lancet Gastroenterology & Hepatology, 2022) [11]. A more recent randomised controlled trial has continued to test CDED in an adult population, adding to a still-developing but genuinely accumulating adult evidence base ("The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial", European Journal of Clinical Investigation, 2025) [10].

The word "pilot" in the 2022 trial's own title matters — this is meaningfully earlier-stage evidence than decades of paediatric EEN data, which is why "promising" rather than "established" is accurate for adults specifically.

The tolerability question, tested directly

One of the strongest practical objections to EEN is that a formula-only diet for weeks is difficult for patients — especially children — to sustain, and a treatment nobody can stick to doesn't help anyone regardless of efficacy on paper. A 2025 randomised controlled trial addressed this directly, comparing a whole-food diet against exclusive enteral nutrition in children and young adults with mild-to-moderate Crohn's disease, finding it induced remission and was more tolerable than EEN [9]. That's a meaningfully different question from "does it work" — it's "will patients actually do it" — and the kind of finding that changes what a clinician can realistically recommend.

A broader network meta-analysis has compared different dietary therapy strategies in active paediatric Crohn's disease, giving a comparative picture across approaches rather than each trial standing alone [3].

What CDED actually restricts

CDED works in structured phases that progressively reduce restriction, combining a defined list of allowed whole foods with a partial enteral nutrition component, rather than removing all normal food the way EEN does. The exclusions target foods and additives hypothesised to affect the gut microbiome and intestinal barrier — a mechanistic rationale, though (as with EEN) the precise mechanism remains genuinely unsettled. Anyone considering it should work from the specific phase structure used in the trials above rather than an informal online summary.

Comparing the three approaches on the evidence

<div style="border:1px solid #ccc;border-radius:8px;padding:16px;margin:16px 0">

EEN, CDED, and Whole Food Diet, by what the trials actually tested

ApproachWhat it involvesPopulation most studiedTolerability finding
Exclusive enteral nutrition (EEN)Liquid formula only, several weeksPaediatric Crohn's, longest track recordEffective but difficult to sustain
CDED + partial enteral nutritionStructured whole-food phases plus partial formulaPaediatric, with growing adult evidenceDirectly shown to induce sustained remission in a randomised trial
Whole Food Diet (no formula)Whole-food-only structured approachChildren and young adultsFound more tolerable than EEN while inducing remission in a 2025 randomised trial

</div>

Where this leaves someone considering it

The evidence favours CDED and whole-food alternatives as genuine, trial-tested options rather than unproven alternative-medicine claims — a different category from most rows on our main diet page. But this is an active, still-maturing evidence base, particularly in adults, and none of these are self-directed interventions: the trials were conducted with structured clinical and dietetic support, and adherence to the published protocol is what the evidence actually covers.

Common questions

Is the Crohn's Disease Exclusion Diet as effective as exclusive enteral nutrition? A randomised trial found CDED combined with partial enteral nutrition induces sustained remission, and a separate 2025 trial found a whole-food version was more tolerable than EEN while also inducing remission — the evidence supports it as a genuine alternative, though EEN still has the longer track record overall.

Can adults use the Crohn's Disease Exclusion Diet, or is it only for children? Adult-specific randomised trials exist, including a 2022 pilot trial and a 2025 randomised controlled trial, but this evidence base is newer and smaller than the paediatric data.

What foods does CDED actually exclude? It follows a structured, phased whole-food plan combined with partial enteral nutrition rather than a simple avoidance list — the specifics matter and should follow the published trial protocols rather than an informal summary.

Do I need a dietitian to try CDED? The trials behind this evidence were conducted with structured clinical support; this is not designed as a self-directed elimination diet.

Why would someone choose a whole-food diet over exclusive enteral nutrition if EEN has more evidence? Tolerability — a 2025 randomised trial found a whole-food approach was more tolerable than EEN while still inducing remission, which matters directly for whether a patient, especially a child, can complete the treatment course at all.

Compound light microscope with objective turret and stage, standing on a bench
Ajay Kumar Chaurasiya · CC BY-SA 4.0 · Wikimedia Commons
The evidence behind this page A stacked bar showing the composition of the 20 publications cited on this page by study type. 884meta-analysis (8)randomised trial (8)review (4)
20 publications, 1994–2026. That is a mix with both trials and syntheses in it, which is the position from which a claim about cause is reasonable. Source: this page’s own citation list, below.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review Gleave A, Shah A, Tahir U, et al. · The American journal of gastroenterology · 2025 · Systematic review DOIPubMed 39056556
  2. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review Hashash JG, Elkins J, Lewis JD, et al. · Gastroenterology · 2024 · Clinical guideline DOIPubMed 38276922
  3. Efficacy of different dietary therapy strategies in active pediatric Crohn's disease: a systematic review and network meta-analysis Ma J, Chong J, Qiu Z, et al. · PeerJ · 2024 · Meta-analysis DOIPubMed 39686992Full text
  4. High-Fiber Diet and Crohn's Disease: Systematic Review and Meta-Analysis Serrano Fernandez V, Seldas Palomino M, Laredo-Aguilera JA, et al. · Nutrients · 2023 · Meta-analysis DOIPubMed 37513532Full text
  5. Dietary Interventions in Ulcerative Colitis: A Systematic Review of the Evidence with Meta-Analysis Herrador-López M, Martín-Masot R, Navas-López VM · Nutrients · 2023 · Meta-analysis DOIPubMed 37836478Full text
  6. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease Sinopoulou V, Gordon M, Akobeng AK, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 34844288Full text
  7. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses Piovani D, Danese S, Peyrin-Biroulet L, et al. · Gastroenterology · 2019 · Meta-analysis DOIPubMed 31014995
  8. ESPEN guideline: Clinical nutrition in inflammatory bowel disease Forbes A, Escher J, Hébuterne X, et al. · Clinical nutrition (Edinburgh, Scotland) · 2017 · Systematic review DOIPubMed 28131521
  9. Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial Aharoni-Frutkoff Y, Plotkin L, Pollak D, et al. · Gastroenterology · 2025 · Randomised controlled trial DOIPubMed 40553742
  10. The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial Pasta A, Formisano E, Calabrese F, et al. · European journal of clinical investigation · 2025 · Randomised controlled trial DOIPubMed 39853756
  11. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial Yanai H, Levine A, Hirsch A, et al. · The lancet. Gastroenterology & hepatology · 2022 · Randomised controlled trial DOIPubMed 34739863
  12. Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease Ghiboub M, Penny S, Verburgt CM, et al. · Gastroenterology · 2022 · Randomised controlled trial DOIPubMed 35679949
  13. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  14. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial Levine A, Wine E, Assa A, et al. · Gastroenterology · 2019 · Randomised controlled trial DOIPubMed 31170412
  15. Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial Gunasekeera V, Mendall MA, Chan D, et al. · Digestive diseases and sciences · 2016 · Randomised controlled trial DOIPubMed 26809868
  16. Nutrition support in inflammatory bowel disease Lewis JD, Fisher RL · The Medical clinics of North America · 1994 · Randomised controlled trial DOIPubMed 7967919
  17. Chronic, Noninfectious Diarrhea: A Review Singh P, Lee A, Sheth NM, et al. · JAMA · 2026 · Review DOIPubMed 41770539
  18. Dietary therapies for adult and pediatric inflammatory bowel disease Deas J, Shah ND, Konijeti GG, et al. · Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2024 · Review DOIPubMed 38505875
  19. Considerations in Paediatric and Adolescent Inflammatory Bowel Disease Vuijk SA, Camman AE, de Ridder L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475081Full text
  20. Mild Crohn's Disease: Definition and Management Claytor J, Kumar P, Ananthakrishnan AN, et al. · Current gastroenterology reports · 2023 · Review DOIPubMed 36753033